CORDYCEPS SUNSHINE BIOTECH HOLD (RAJAF)
- Previous Close
0.00 - Open
9.22 - Bid 9.00 x 21500
- Ask 11.00 x --
- Day's Range
9.22 - 9.22 - 52 Week Range
0.04 - 9.22 - Volume
100 - Avg. Volume
6 - Market Cap (intraday)
1.025B - Beta (5Y Monthly) --
- PE Ratio (TTM)
∞ - EPS (TTM)
0.00 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cordyceps Sunshine Biotech Holdings Co., Ltd. engages in the research, development, cultivation, processing, and sale of cordyceps for distributors and retail customers in China. It offers dry and fresh cordyceps, which is a species of parasitic fungus that is used as a Chinese medicinal material. The company was incorporated in 2020 and is based in Taipei, Taiwan.
15
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Performance Overview: RAJAF
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RAJAF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RAJAF
View MoreValuation Measures
Market Cap
1.02B
Enterprise Value
1.03B
Trailing P/E
4.24k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.16k
Price/Book (mrq)
--
Enterprise Value/Revenue
1.16k
Enterprise Value/EBITDA
2.78k
Financial Highlights
Profitability and Income Statement
Profit Margin
93.35%
Return on Assets (ttm)
5.10%
Return on Equity (ttm)
--
Revenue (ttm)
882.53k
Net Income Avi to Common (ttm)
241.54k
Diluted EPS (ttm)
0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
15.28k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
583.5k